Publications in collaboration with researchers from Yale School of Medicine (1)

2026

  1. Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab

    Clinical Cancer Research, Vol. 32, Núm. 6, pp. 1036-1045